{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-011142","form_type":"8-K","ticker":"SYRA","cik":"0001922335","company_name":"Syra Health Corp","filed_at":"2024-03-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.315116+00:00","generated_at":"2026-06-04T08:47:26.977471+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Syra Health 2023 revenue $5.5M, net loss $2.94M; projects 64-100% growth in 2024","bullets":["FY2023 revenue $5.5M, net loss $(2.94M), vs $5.6M and $(2.12M) in 2022.","Gross profit margin improved 670 bps to 25.6% from 18.9% in 2022 on mix shift to higher-margin units.","Adjusted EBITDA loss widened to $(2.8M) from $(2.1M); cash balance $3.3M with no long-term debt.","Guides FY2024 revenue of $9-$11M (64-100% growth), excluding potential revenue from recent Caduceus federal contract."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-011142","json":"https://secwatch.observer/filing/0001493152-24-011142.json","markdown":"https://secwatch.observer/filing/0001493152-24-011142.md","text":"https://secwatch.observer/filing/0001493152-24-011142.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1922335/000149315224011142/0001493152-24-011142-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1922335/000149315224011142/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T08:47:26.977471+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2212174111dc7f5b21abb228f598c34c4cf446e6","claim":"Syra Health Corp reported the fourth quarter and fiscal year ended December 31, 2023 results: revenue $5.5 million, net income $(2.94 million). Guidance reaffirmed.","evidence_excerpt":"and technology solutions, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2023. 2023 Financial Highlights ● 2023 revenue of $5.5 million compared to $5.6 million in 2022. ● Business units excluding Healthcare Workforce grew 250% and comprised 23% of total revenues in 2023, versus only 6% in 2022. ● Population","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1922335/000149315224011142/0001493152-24-011142-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter and fiscal year ended December 31, 2023"},{"label":"Revenue","value":"$5.5 million"},{"label":"Net income","value":"$(2.94 million)"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"f52558179f83e39861fbb267cb36db97e641a107","claim":"Syra Health Corp reported full-year 2024 results: revenue $9 to $11 million. Guidance initiated.","evidence_excerpt":"The Company expects full-year 2024 revenue of $9 to $11 million, representing a growth of 64%-100% versus 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1922335/000149315224011142/0001493152-24-011142-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full-year 2024"},{"label":"Revenue","value":"$9 to $11 million"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}